Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 75868663 | 7586866 | 3 | F | 20100901 | 20160824 | 20100915 | 20160830 | EXP | BR-PFIZER INC-2010113974 | PFIZER | 60.00 | YR | F | Y | 84.50000 | KG | 20160830 | OT | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 75868663 | 7586866 | 1 | PS | NAPROXEN. | NAPROXEN | 1 | Oral | UNK | Y | 0 | TABLET | ||||||||
| 75868663 | 7586866 | 2 | SS | NAPROXEN. | NAPROXEN | 1 | Y | 0 | TABLET | ||||||||||
| 75868663 | 7586866 | 3 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 20 OR 40 MG, DAILY | 16700 | MG | 0 | ||||||||
| 75868663 | 7586866 | 4 | C | TAPAZOL | 2 | Oral | 20 MG, 1X/DAY | 0 | 20 | MG | TABLET | QD | |||||||
| 75868663 | 7586866 | 5 | C | ENALAPRIL | ENALAPRIL | 1 | Oral | 20 MG, 2X/DAY | 0 | 20 | MG | TABLET | BID | ||||||
| 75868663 | 7586866 | 6 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Oral | 25 MG, 1X/DAY | 0 | 25 | MG | TABLET | QD | ||||||
| 75868663 | 7586866 | 7 | C | ASPIRIN ^BAYER^ | ASPIRIN | 1 | Oral | 100 MG, 1X/DAY | 0 | 100 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 75868663 | 7586866 | 1 | Osteoarthritis |
| 75868663 | 7586866 | 2 | Rheumatoid arthritis |
| 75868663 | 7586866 | 3 | Gastritis prophylaxis |
| 75868663 | 7586866 | 4 | Hyperthyroidism |
| 75868663 | 7586866 | 5 | Hypertension |
| 75868663 | 7586866 | 6 | Hypertension |
| 75868663 | 7586866 | 7 | Cardiovascular disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 75868663 | 7586866 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 75868663 | 7586866 | Angina unstable |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 75868663 | 7586866 | 1 | 20080520 | 20100901 | 0 | |
| 75868663 | 7586866 | 3 | 20080520 | 20100901 | 0 | |
| 75868663 | 7586866 | 4 | 1998 | 0 | ||
| 75868663 | 7586866 | 5 | 2000 | 0 | ||
| 75868663 | 7586866 | 6 | 20080722 | 0 | ||
| 75868663 | 7586866 | 7 | 20091029 | 0 |